NCT03036761 (Migauric) is a NA clinical trial of Auriculotherapy in Headache, Migraine, sponsored by Hopital Foch.

Who is sponsoring NCT03036761?

NCT03036761 is sponsored by Hopital Foch.

What drugs are being tested in NCT03036761?

Interventions in NCT03036761: Auriculotherapy.

What condition does NCT03036761 study?

NCT03036761 studies Headache, Migraine.

Is NCT03036761 still recruiting?

NCT03036761 is currently completed. Last updated 21 April 2021.

Last reviewed 2021-04-21 · How we verify

NCT03036761: Migauric

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Interest of Auriculotherapy in Prophylaxis of Migraine and Headache in Patients With Migraines

Completed NA Last updated 21 April 2021

What this trial tests

NA trial testing Auriculotherapy in Headache, Migraine in 90 participants. Completed in 22 March 2021.

Timeline

18 January 2017

Primary endpoint
14 December 2020

22 March 2021

Quick facts

Lead sponsor	Hopital Foch
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	90
Start date	18 January 2017
Primary completion	14 December 2020
Estimated completion	22 March 2021
Sites	4 locations across France

Drugs / interventions tested

Auriculotherapy — full drug profile →

Conditions studied

Headache, Migraine — all drugs for Headache, Migraine →

Sponsor

Hopital Foch — full company profile →

Who can join

Adults 18 Months to 80, female only, with Headache, Migraine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to show that auriculotherapy decreases the number of days with painful episodes of migraine and headache after 3 months of treatment

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Auriculotherapy in prevention of migraine attacks: an open randomized trial.
Michel-Cherqui M, Ma S, d'Ussel M, Ebbo D, et al · · 2023 · cited 4× · PMID 37284181 · DOI 10.3389/fneur.2023.1193752

Verify or expand the search:

Other trials of Auriculotherapy

Trials testing the same drug.

NCT06273488 — The Role of Auricular Point Diagnosis and Treatment in ERAS During TKA · completed
NCT05042778 — Is Auriculotherapy Responsible for Improvements on Anxiety Students' Prior and After Examinations? · NA · completed
NCT05126615 — Contribution of Auriculotherapy in the Management of Mastectomy With Immediate Reconstruction by Latissimus Dorsi Flap ( · NA · terminated
NCT02767791 — Auriculotherapy and Acupuncture's Treatment for Chemotherapy-induced Nausea and Vomiting (CINV) · NA · completed

Other recruiting trials for Headache, Migraine

Currently open trials in the same condition.

NCT06584409 — Migraines Accepted Laser Acupuncture Compared in Blood Test of MMP2 and CGRP · NA · recruiting
NCT05889624 — Responding With Evidence and Access for Childhood Headaches · NA · recruiting
NCT05232942 — Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption · recruiting
NCT04715685 — Mind Body Balance for Pediatric Migraine · NA · recruiting

Other Hopital Foch trials

Trials by the same sponsor.

NCT06980844 — Interpretation of the Role of Eosinophils in Diffuse Interstitial Pneumopathies · NA · not yet recruiting
NCT06757244 — DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer · Phase 2 · recruiting
NCT06631794 — Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students · not yet recruiting
NCT06533436 — Clinical and Economic Comparison of 2 Methods of Intubation Tube Fixation : AnchorFastTM Versus Current Cord Fixation · NA · recruiting
NCT06476002 — Analysis of the Understanding of the French Version of the Vulvar Pain Assessment Questionnaire · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03036761 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hopital Foch
Last refreshed: 21 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03036761.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing